ClinConnect ClinConnect Logo
Search / Trial NCT06583382

Cementation of Cup and the Risk of Second Revision

Launched by BISPEBJERG HOSPITAL · Sep 2, 2024

Trial Information

Current as of November 12, 2025

Not yet recruiting

Keywords

Cup Cementation Total Hip Arthroplasty Tha Revision Second Revision Re Revision Cement

ClinConnect Summary

This clinical trial is studying how the method used to secure the acetabular component (the socket part of the hip joint) during the initial total hip replacement surgery affects the likelihood of needing a second surgery later on. The researchers are particularly interested in comparing two techniques: using cement to fix the cup in place versus not using cement. They want to see if one method leads to a higher risk of needing further revisions to the hip joint.

To take part in this study, participants should be between the ages of 65 and 74 and have had their first hip replacement due to primary osteoarthritis. They must have had a revision surgery where the liner or socket was replaced, and they should have specific sizes of the femoral component. However, those who only had the femoral component revised or have certain types of implants won’t be eligible. While the study is not yet recruiting participants, once it starts, those enrolled can expect to provide information about their surgeries and health, helping researchers understand the best practices for hip replacement surgeries.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Primary osteoarthritis as the indication for the primary THA.
  • Has experienced a first revision with exchange of the liner, femoral head and/or acetabular component either with or without exchange of the femoral component.
  • Femoral with a size of 28mm, 32mm or 36mm after the first revision
  • Surgery with the posterior approach.
  • Exclusion Criteria:
  • Isolated revision of the femoral component.
  • Constrained liner.
  • Metal-on-metal implant.

About Bispebjerg Hospital

Bispebjerg Hospital is a leading healthcare institution located in Copenhagen, Denmark, renowned for its commitment to innovative medical research and clinical excellence. As a key sponsor of clinical trials, the hospital focuses on advancing healthcare by exploring novel therapies and treatment protocols across various medical disciplines. With a multidisciplinary team of experienced researchers and clinicians, Bispebjerg Hospital aims to enhance patient outcomes through rigorous scientific inquiry and evidence-based practices, while fostering collaboration with academic institutions and industry partners to drive progress in the medical field.

Locations

Patients applied

0 patients applied

Trial Officials

Søren Overgard, MD, PhD, DMSc

Study Director

Department of Orthopedic surgery and traumatology, Hvidovre Hospital, Copenhagen, Denmark

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported